Richard F Riedel (Richard Riedel)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Locally Advanced

Neoadjuvant Chemotherapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Oluwadamilola M Fayanju, Richard F Riedel, Emilia J Diego, Amanda L Nash, Juneko E Grilley-Olson, Natalie A Danziger, Ethan S Sokol, Jeffrey S Ross, Sarah L Sammons
Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities. The oncologist (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Ajay Gupta, Matthew S Dietz, Richard F Riedel, Aditi Dhir, Scott C Borinstein, Michael S Isakoff, Jamie M Aye, Nino Rainusso, Amy E Armstrong, Steven G DuBois, Lars M Wagner, Jeremy M Rosenblum, Sarah Cohen-Gogo, Catherine M Albert, Stacey Zahler, Rashmi Chugh, Matteo Trucco
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board. Cancer (2024)
Paul A Meyers, Noah Federman, Najat C Daw, Peter M Anderson, Lara E Davis, AeRang Kim, Margaret E Macy, Angela Pietrofeso, Ravin Ratan, Richard F Riedel, Matteo Trucco, James B Breitmeyer, Jeffrey A Toretsky, Joseph A Ludwig
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Elizabeth Trice Loggers, Rashmi Chugh, Noah Federman, Lee Hartner, Richard F Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B Oton, Kutluk H Oktay
Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study. Cancer (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elizabeth Trice Loggers, Rashmi Chugh, Noah Federman, Lee Hartner, Richard F Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B Oton, Kutluk H Oktay
Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study. Cancer 130 (16) (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ajay Gupta, Richard F Riedel, Chirag A Shah, Scott C Borinstein, Michael S Isakoff, Rashmi Chugh, Jeremy M Rosenblum, Erin S Murphy, Shauna R Campbell, Catherine M Albert, Stacey Zahler, Stefanie M Thomas, Matteo Trucco
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board. Cancer (2023)
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martín-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Richard F Riedel, Silvia Stacchiotti, Elizabeth Trice Loggers, Kristen N Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier García Del Muro Solans, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F Mulcahy, Charles Forscher, Nicolas Penel, Scott H Okuno, Anthony D Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore D F Lapeire, Jean Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K Schwartz, James L Chen, Hari Deshpande, Elizabeth J Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F Meyer, Margaret von Mehren, Brian Andrew Van Tine, Katharina S Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T J Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A Dickson, Dayana Michel, Chang-Ting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R Van Domelen, Christopher J Walker, Hua Chang, Yosef Landesman, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Steven Attia
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Richard F Riedel, Mark Agulnik
Evolving strategies for management of desmoid tumor. Cancer 128 (16) (2022)
Richard F Riedel, Victoria Chua, Ania Moradkhani, Natalie Krkyan, Amir Ahari, Atsushi Osada, Sant P Chawla
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma. The oncologist 27 (10) (2022)
Sant P Chawla, Brian Andrew Van Tine, Seth M Pollack, Kristen N Ganjoo, Anthony D Elias, Richard F Riedel, Steven Attia, Edwin Choy, Scott H Okuno, Mark Agulnik, Margaret von Mehren, Michael B Livingston, Vicki L Keedy, Claire F Verschraegen, Tony Philip, G Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen, Robert G Maki
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Berta Grigorian, Anita N Schmid, Shihe Hou, Katherine Harris, David J Kwiatkowski, Neil P Desai, Mark A Dickson
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Sant P Chawla, Sanjay Goel, Warren Chow, Fadi Braiteh, Arun S Singh, Juneko E Grilley Olson, Atsushi Osada, Iulian Bobe, Richard F Riedel
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Emily Z Keung, Melissa Burgess, Ruth Salazar, Edwin R Parra, Jaime Rodrigues-Canales, Vanessa Cilento, Brian Andrew Van Tine, Scott M Schuetze, Steven Attia, Richard F Riedel, James Hu, Scott H Okuno, Dennis A Priebat, Sujana Movva, Lara E Davis, Damon R Reed, Alexandre Reuben, Christina L Roland, Denise Reinke, Alexander J F Lazar, Wei-Lien Wang, Jennifer A Wargo, Hussein A Tawbi
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2020)
Richard F Riedel, Karla V Ballman, Yao Lu, Steven Attia, Elizabeth T Loggers, Kristen N Ganjoo, Michael B Livingston, Warren Chow, Jennifer Wright, John H Ward, Daniel Rushing, Scott H Okuno, Damon R Reed, David A Liebner, Vicki L Keedy, Leo Mascarenhas, Lara E Davis, Christopher Ryan, Denise K Reinke, Robert G Maki
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study. The oncologist 25 (11) (2020)
Jennifer Choe, Richard F Riedel
Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas. F1000Research 7 (2018)